Results 101 to 110 of about 82,129 (320)

Clinical effectiveness of procalcitonin‐ or C‐reactive protein‐guided antibiotic discontinuation protocols for adult patients who are critically ill with sepsis: a rapid systematic review and meta‐analysis

open access: yesAnaesthesia, EarlyView.
Summary Introduction Antibiotics are a first‐line treatment for sepsis, with guidelines recommending a 7‐ to 10‐day course. Prolonged antibiotic use carries significant risks, prompting growing interest in using inflammatory biomarkers, such as procalcitonin or C‐reactive protein, to guide clinical decision‐making on the duration of antibiotic therapy ...
Sonya Rafiq   +6 more
wiley   +1 more source

National action plan on antimicrobial resistance in selected Asia-Pacific low- and middle-income countries: Perspectives of One Health stakeholders

open access: yesOne Health
Antimicrobial resistance (AMR) is a One Health problem worldwide, with low and middle-income countries (LMICs) identified as hotspots for AMR development.
Yasodhara D. Gunasekara   +7 more
doaj   +1 more source

Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
BQT remains the most effective, safe, and practical regimen for H. pylori eradication, ensuring high cure rates across diverse resistance patterns and clinical settings. ABSTRACT Background Classic bismuth quadruple therapy (BQT)—the combination of a proton pump inhibitor, bismuth, tetracycline, and metronidazole—is a standard regimen for treating ...
Javier P. Gisbert   +2 more
wiley   +1 more source

Can we prevent antimicrobial resistance by using antimicrobials better? [PDF]

open access: yes, 2013
Since their development over 60 years ago, antimicrobials have become an integral part of healthcare practice worldwide. Recently, this has been put in jeopardy by the emergence of widespread antimicrobial resistance, which is one of the major problems ...
Brown   +27 more
core   +2 more sources

Bridging Global Disparities in Drug Allergy Through AI‐Assisted Training for Non‐Specialists: Findings From the Multinational ADAPT‐2 Course

open access: yesClinical &Experimental Allergy, EarlyView.
The multinational ADAPT‐2 initiative conducted in Australia, Hong Kong, mainland China and Sri Lanka demonstrated that AI‐assisted training is effective in addressing the significant disparities between advanced and emerging economies in non‐specialist physicians' drug allergy knowledge and confidence.
Hugo W. F. Mak   +18 more
wiley   +1 more source

203. Opportunities for Antimicrobial Stewardship in Febrile Neutropenia [PDF]

open access: gold, 2020
Christopher Shoff   +8 more
openalex   +1 more source

Temporohyoid osteoarthropathy: Recurrence of clinical signs following standing partial ceratohyoidectomy in a Swiss Warmblood mare

open access: yesEquine Veterinary Education, EarlyView.
Summary A 17‐year‐old Swiss Warmblood mare presented with signs of left‐sided facial nerve paralysis and was diagnosed with left‐sided temporohyoid osteoarthropathy (THO). A partial ceratohyoidectomy was performed in the standing, sedated mare to treat this condition.
J. Kuhlmann   +5 more
wiley   +1 more source

Successful Treatment of Klebsiella pneumoniae Harboring a Klebsiella pneumoniae Carbapenemase Isolated from Lumbar Wound Infection and Blood in a Patient with Hardware Retention

open access: yesCase Reports in Infectious Diseases, 2017
Infections caused by carbapenem-resistant Enterobacteriaceae, especially carbapenemase producing Klebsiella pneumoniae, represent an urgent threat as outlined by the Centers for Disease Control and Prevention (CDC).
Alan Bulbin   +4 more
doaj   +1 more source

Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) [PDF]

open access: yes, 2016
Intra-abdominal infections (IAI) are an important cause of morbidity and are frequently associated with poor prognosis, particularly in high-risk patients.
A   +173 more
core   +4 more sources

Home - About - Disclaimer - Privacy